Statin use and need for therapy in chronic lymphocytic leukemia

Leuk Lymphoma. 2010 Dec;51(12):2295-8. doi: 10.3109/10428194.2010.520050. Epub 2010 Oct 7.
No abstract available

Publication types

  • Evaluation Study
  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Apolipoproteins E / genetics
  • Disease-Free Survival
  • Female
  • Genotype
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Prognosis
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Apolipoproteins E
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors